Type 2 Diabetes Mellitus Flashcards

1
Q

Define Diabetes Mellitus Type 2

A

Chronic syndrome of impaired carbohydrate, protein and fat metabolism characterised by increased peripheral target-tissue resistance to insulin action, impaired insulin secretion and a raised hepatic glucose output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the aetiology of T2DM

A

Insulin resistance + impaired secretion → hyperglycaemia
Insulin resistance primarily affects the liver, muscle and adipocytes
BG genetic predisposition (90% MZ twin concordance)
Secondary to
- pancreatic disease: chronic pancreatitis, haemochromatosis, pancreatic cancer, iatrogenic
- Endocrine: Cushing’s, acromegaly, phaeos, glucagonoma
- Drugs e.g. steroids, antipsychotics, protease inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the risk factors for T2DM

A

Strong family history
Obesity or overweight
Older age
Physical inactivity
Black or Asian ethnicity
Hypertension
Lipid disorders (hypercholesterolaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the symptoms of T2DM

A

Asymptomatic
Tiredness, fatigue
Blurred vision
Polyuria, polydipsia, nocturia
Paraesthesia
Polyphagia
Increased risk of infections: foot ulcers, candidiasis, balanitis, pruritus vulvae, cellulitis, UTIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the signs of T2DM on examination

A

BMI: raised
BP: ?HTN
Skin:
- Acanthosis nigricans (Light brown-black marking on the neck, on the axillar or on the groin)
- Necrobiosis lipodica (well-demarcated plaques on shins/arms with shiny atrophic surface and red-brown edges)
- Granuloma annulare (flesh-coloured papules coalescing in rings on hands and fingers)
- Diabetic dermopathy (depressed pigmented scars on shins)
Diabetic foot: dry skin, reduced SC tissue corns, calluses, ulceration, gangrene, Charcot’s arthropathy, reduced/absent foot pulses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What investigations should be done for T2DM

A

Bedside: BM, urine dip, urinary ketones (+ve = T1DM, -ve = T2), ECG, fundoscopy
Bloods
- Random plasma glucose: >11
- Fasting plasma glucose: >6.9
- HbA1c: >48 (glucose for 2-3 months)
– <7 = impaired glucose tolerance
- OGTT >11.1 (impaired = 7.9-11.1) - for borderline/GDM
- Plasma ketones: negative (diff from T1)
- Fasting C peptide: >1 (diff from T1)
- Auto-immune markers: -ve
- Fasting lipid: often normal, may be raised
- Renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the management for T2DM

A
  1. Lifestyle changes: Personalised self-management programme, usually developed by a diabetes education nurse or nutritionist.
  2. Glycaemic management
  3. Monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the lifestyle changes recommended to those with T2DM

A

Limiting caloric intake
High fibre, low glycaemic index carbs
Low-fat dairy products and oily fish
Moderate physical activity (improve control, weight maintenance, CV risk reduction): 3-4 aerobic activities per week
Weight loss
Reduce alcohol intake
Smoking cessation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the options for glycaemic control in T2DM

A

After lifestyle advice → HbA1c remains >48 →
1. Metformin
- IF high-risk/established CVD/CHF/QRISK >10%→ add SGLT-2 inhibitor
- If not tolerated → switch to modified release
2. Titrate up metformin + encourage lifestyle changes

Only add a second drug if >58
3. Metformin + DPP4i, pioglitazone, SU, SGLTI-2i
4. Metformin + 2 glycaemic control drugs OR insulin
5. Switch one drug for a GLP-1 mimetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of a drug from each class for diabetic control

A

Biguanide - metformin
Sulphonylurea - glibenclamide
Thiazolidinedione - pioglitazone
DPP4-inhibitor - gliptin (PO)
SGLT-2 inhibitors - empagliflozin
GLP-1 analogues - liraglutide, exenatide (SC injection within 60mins BEFORE morning and evening meals)

PCSK-9 inhibitors - evolocumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What monitoring should be done for T2DM

A

Hypertension
Dyslipidaemia
Albuminuria (Kidney disease) via ACR
Retinopathy (refer)
Periodontitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the complications of T2DM

A

Hyperosmolar hyperglycaemic state (HHS)
Microvascular: retinopathy, neuropathy, nephropathy
Macrovascular:
Diabetic foot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the HbA1c targets for those with T2DM

A

HbA1c should be checked every 3-6 months until stable, then 6 monthly

Lifestyle only: 48 (6.5%)
Lifestyle + metformin: 48 (6.5%)
Any drug that can cause hypoglycaemia: 53 (7/0%)
Already on monotherapy but HbA1c has risen to 58: 52 (7/0%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the sick day rules for type 2 diabetes

A

Temporarily stop some oral hypoglycaemics during an acute illness
medication may be restarted once the person is feeling better and eating and drinking for 24-48 hours

metformin: stop treatment if there is a risk of dehydration, to reduce the risk of lactic acidosis.
SGLT-2: stop in DKA
GLP-1: stop if risk of dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side effects of T2DM medication

A

Metformin
- GI disturbance e.g. N&V, diarrhoea, pain
+ weight loss

Sulphonylureas (gliclazide/glibenclamide):
- Hypoglycaemia
- Weight gain
- GI disturbance (N&V)
- SJS

DPP4i (gliptins)
+ weight neutral

Thiazolidinediones (pioglitazone)
- Weight gain
- CI in heart failure and bladder cancer

SGLT-2i (Empagliflozin)
- Fournier’s gangrene (necrotising fasciitis of the genitalia)
- Recurrent thrush
- CI in active foot disease
+ weight loss

GLP-1 analogues (liraglutide)
+ weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly